The pharmaceutical industry plays a pivotal role in healthcare, working to develop innovative medicines that save lives and improve quality of life for millions of Americans. In the United States, …
The Center for Innovation and Free Enterprise (CIFE) opposes the “reasonable pricing” amendment proposed by Senator Sanders to the Pandemic and All Hazards Preparedness Act (PAHPA). While CIFE acknowledges the …
The healthcare industry has been witnessing a steady stream of groundbreaking discoveries and advancements in the field of medicine. These innovations have played a crucial role in improving the quality …
The Center for Innovation and Free Enterprise opposes the recently introduced Strengthening Medicare and Reducing Taxpayers (SMART) Prices Act. This bill aims to expand on the price controls established in …
In recent years, the healthcare industry has witnessed an ongoing debate surrounding rising drug prices and the role played by various stakeholders. Amidst this discourse, profit-driven Pharmacy Benefit Managers (PBMs) …
As the 118th Congress begins to explore ways to lower the rising cost of healthcare, we believe lawmakers need to address an issue that affects millions of Americans insured in …
Intellectual property (IP) is a crucial component of innovation and creativity. In recent years, elected officials have increasingly recognized the importance of IP and have spoken out in support of …
As we celebrate World Intellectual Property Day in 2023, the Center for Innovation and Free Enterprise recognizes the critical role that women play in driving innovation and creativity across all …
CIFE strongly opposes the expansion of the TRIPS waiver. Intellectual property rights are essential for promoting innovation, investment, and economic growth. The TRIPS agreement already provides adequate flexibilities to ensure …
The Senate HELP Committee is gearing up for a full committee hearing tomorrow on the price of COVID vaccines. Due to this and the push from price control proponents, we …
